A new study shows that the transcription factor Tlx3 specifies glutamatergic phenotype and suppresses GABAergic markers during spinal cord development. Understanding this process could ultimately lead to 'customized' neurons for transplantation.
Access options
Subscribe to Journal
Get full journal access for 1 year
$225.00
only $18.75 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
from$8.99
All prices are NET prices.
References
- 1.
Caspary, T. & Anderson, K.V. Nat. Rev. Neurosci. 4, 289–297 (2003).
- 2.
Sharma, K. et al. Cell 95, 817–828 (1998).
- 3.
Cheng, L. et al. Nat. Neurosci. 510–517 (2004).
- 4.
Mann, R.S. & Carroll, S.B. Curr. Opin. Genet. Dev. 12, 592–600 (2002).
- 5.
Qian, Y., Shirasawa, S., Chen, C.L., Cheng, L. & Ma, Q. Genes Dev. 16, 1220–1233 (2002).
- 6.
Gross, M.K., Dottori, M. & Goulding, M. Neuron 34, 535–549 (2002).
- 7.
Qian, Y. et al. Genes Dev. 15, 2533–2545 (2001).
- 8.
Wichterle, H., Lieberam, I., Porter, J.A. & Jessell, T.M. Cell 110, 385–397 (2002).
- 9.
Barberi, T. et al. Nat. Biotechnol. 21, 1200–1207 (2003).
- 10.
Thompson, K. et al. Exp. Neurol. 161, 481–489 (2000).
- 11.
Kim, J.Y. et al. J. Neurochem. 85, 1443–1454 (2003).
Author information
Affiliations
Stewart Anderson is in the Departments of Psychiatry and Neurology, Weill Medical College of Cornell University, 1300 York Avenue, New York, New York 10021, USA. saa2007@med.cornell.edu
- Stewart Anderson
Authors
Search for Stewart Anderson in:
Rights and permissions
To obtain permission to re-use content from this article visit RightsLink.
